Peer-reviewed studies distilled into actionable summaries. Updated daily.
Total: 58,237 articles• Showing 2 of 58,237
pubmed
Inference of upstream-mutation and metabolomic-signature causality identifies prognostic biomarkers and therapeutic targets in pancreatic cancer.
Chen F; Lou X; Guo X; Guo Y; Huang Y; Li K; Song Y; Li J; Wang J; Lin K; Tian R; Wang M; Dai X; Fang H; Cui W
Scientists found a way to use special molecules in the blood to understand more about a type of cancer in the pancreas. They discovered some key molecules that could predict how well a person might do with their treatment and identified a gene that could help with new treatments.
View Details
pubmed
Multi-ancestry transcriptome-wide association studies uncover insights into breast cancer genetics and biology.
Ping J; Jia G; Cai Q; Guo X; Wang J; Tao R; Li B; Bauer JA; Xie Y; Ambs S; Barnard ME; Chen Y; Choi JY; Gao YT; Garcia-Closas M; Gu J; Hu JJ; Iwasaki M; John EM; Kweon SS; Li CI; Matsuda K; Matsuo K; Nathanson KL; Nemesure B; Olopade OI; Pal T; Park SK; Park B; Press MF; Sanderson M; Sandler DP; Yao S; Zheng Y; Ahearn T; Brewster AM; Falusi A; Hennis AJM; Ito H; Kubo M; Lee ES; Makumbi T; Mapoko BSE; Noh DY; O'Brien KM; Ojengbede O; Olshan AF; Park MH; Reid S; Yamaji T; Zirpoli G; Butler EN; Huang M; Low SK; Obafunwa J; Weinberg CR; Zhang H; Zhao H; Ambrosone CB; Cote ML; Huo D; Haiman CA; Kang D; Palmer JR; Troester MA; Shu XO; Long J; Zheng W
Researchers studied genes linked to breast cancer and found 290 genes that might be involved, including some that weren't known before. They used data from many women and special techniques to figure out how genes might affect cancer risk. Some genes are related to cancer differently depending on estrogen receptor status.
View Details
🔒
Unlock 58,235+ More Articles
Upgrade to the Weekly Digest and get unlimited access to all research articles,
plain-language takeaways, and our AI research assistant.
or
Get the science breakthroughs you need— every Tuesday morning.
We scan 70+ journals so you don't have to. One email. Zero jargon. Unsubscribe anytime.
